[1]谢丽圣.复方七芍降压片对自发性高血压大鼠血压及左心室肥厚的影响[J].陕西中医,2022,(9):1191-1195.[doi:DOI:10.3969/j.issn.1000-7369.2022.09.008]
　XIE Lisheng.Effect of compound Qishao Jiangya tablet on blood pressure and left ventricular hypertrophy in spontaneously hypertensive rats[J].,2022,(9):1191-1195.[doi:DOI:10.3969/j.issn.1000-7369.2022.09.008]
点击复制

复方七芍降压片对自发性高血压大鼠血压及左心室肥厚的影响

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2022年9期
页码:
1191-1195
栏目:
基础研究
出版日期:
2022-09-05

文章信息/Info

Title:
Effect of compound Qishao Jiangya tablet on blood pressure and left ventricular hypertrophy in spontaneously hypertensive rats
作者:
谢丽圣
(南宁市第二人民医院,广西 南宁 530021)
Author(s):
XIE Lisheng
(Nanning Second People's Hospital,Nanning 530021,China)
关键词:
高血压;  复方七芍降压片;  缬沙坦;  降压;  血管紧张素Ⅱ;  大鼠
Keywords:
Hypertensive;  Compound Qishao Jiangya tablet;  Valsartan;  Depressurization;  Ang-Ⅱ;  Rats
分类号:
R 544.1
DOI:
DOI:10.3969/j.issn.1000-7369.2022.09.008
文献标志码:
A
摘要:
目的:探讨复方七芍降压片的降压及逆转左室肥厚作用。方法:将血压正常大鼠15只作为空白组; 将自发性高血压大鼠45只,随机分为模型组、复方七芍降压片组、缬沙坦组,并分别给予10 ml/(kg·d)的蒸馏水、复方七芍降压片、缬沙坦,灌胃。采用无创大鼠尾动脉血压测定系统监测血压; 超声心动图测定大鼠心脏结构; 观察心脏大体形态及计算左心室质量指数、相对室壁厚度; 查看心肌组织病理特征; 检测心室肥厚血清学指标及心肌和血浆血管紧张素-Ⅱ(Ang-Ⅱ)。结果:给药后复方七芍降压片组、缬沙坦组大鼠血压较治疗前均有下降,且均低于模型组,差异有统计学意义(均P<0.05)。高血压左室肥厚大鼠给予复方七芍降压片或缬沙坦,治疗后两组大鼠心脏功能有所恢复。治疗后,复方七芍降压片组、缬沙坦组大鼠的心脏较模型组大鼠心脏体积、心肌细胞横截面积均改善。复方七芍降压片组、缬沙坦组大鼠的左心室心肌质量指数、相对室壁厚度均小于模型组大鼠,差异有统计学意义(均P<0.05)。复方七芍降压片组、缬沙坦组大鼠的心室肥厚血清Ⅲ型前胶原(PCⅢ)、层粘连蛋白(LN)、透明质酸(HA)均小于模型组,差异有统计学意义(均P<0.05)。结论:复方七芍降压片对高血压大鼠有降压,逆转左室肥厚作用。
Abstract:
Objective:To investigate antihypertensive effect of compound Qishao Jiangya tablet and reverse hypertensive left ventricular hypertrophy.Methods:15 rats with normal blood pressure were used as control group.45 spontaneously hypertensive rats were randomly divided into model group,compound Qishao Jiangya tablet group and valsartan group,which were given 10 ml /(kg·d)of distilled water,compound Qishao Jiangya tablet or valsartan respectively by gavage respectively.Blood pressure was monitored by non-invasive blood pressure measuring system of rat caudal artery.The heart structure of rats was determined by echocardiography.The general shape of the heart was observed,and the left ventricular mass index relative wall thickness were calculated.The pathological features of myocardial tissue were examined.Serological indexes of ventricular hypertrophy myocardial and plasma Ang-Ⅱ were detected.Results:After administration of compound Qishao Jiangya tablet and valsartan,blood pressure of rats in the compound Qishao Jiangya tablet group and the valsartan group were decreased,which were lower than those in the model group,difference statistically significant(all P<0.05).Rats with hypertensive left ventricular hypertrophy were treated with compound Qishao Jiangya tablet or valsartan,heart function recovered in both groups.After treatment,the compound Qishao Jiangya tablet group and the valsartan group of the heart volume and cross-sectional area of myocardial cells were significantly reduced.After treatment,the compound Qishao Jiangya tablet group and the valsartan group of left ventricular myocardial mass index and relative ventricular wall thickness were lower than those in the model group,difference statistical significance(P<0.05).The serum PCⅢ,LN,HA in the compound Qishao Jiangya tablet group and the valsartan group were lower than those in the model group,differences statistically significant(all P<0.05).Conclusion:Compound Qishao Jiangya tablet can reduce blood pressure and reverse left ventricular hypertrophy in hypertensive rats.

参考文献/References:

[1] Pandey A,Keshvani N,Ayers C,et al.Association of cardiac injury and malignant left ventricular hypertrophy with risk of heart failure in African Americans:The Jackson heart study[J].JAMA Cardiol,2019,4(1):51-58.
[2] Reyes DR,Gomes MJ,Rosa CM,et al.Exercise during transition from compensated left ventricular hypertrophy to heart failure in aortic stenosis rats[J].Journal Cell Mol Medicine,2019,23(2):1235-1245.
[3] Yildiz M,Oktay AA,Stewart MH,et al.Left ventricular hypertrophy and hypertension[J].Prog Cardiovasc Dis,2020,63(1):10-21.
[4] Fan Z,Wu G,Yue M,et al.Hypertension and hypertensive left ventricular hypertrophy are associated with ACE2 genetic polymorphism[J].Life Sci,2019,22(5):39-45.
[5] Cuspidi C,Facchetti R,Quarti TF,et al.Left ventricular hypertrophy in isolated and dual masked hypertension[J].Journal Clin Hypertens,2020,22(4):673-677.
[6] Yang Y,Wang Y,Gao PJ.Osteopontin associated with left ventricular hypertrophy and diastolic dysfunction in essential hypertension[J].Journal Hum Hypertens,2020,34(5):388-396.
[7] Cao X,Broughton ST,Waits GS,et al.Interrelations between hypertension and electrocardiographic left ventricular hypertrophy and their associations with cardiovascular mortality[J].Am Journal Cardiol,2019,123(2):274-283.
[8] Cuspidi C,Facchetti R,Quarti TF,et al.Incident left ventricular hypertrophy in masked hypertension[J].Hypertension,2019,74(1):56-62.
[9] 陈 橙,段吾磊,周 骞,等.复方七芍降压片对高血压前期患者的防治研究[J].中西医结合心脑血管病杂志,2017,15(11):1330-1333.
[10] 王 婷,张 稳,罗 勇,等.复方七芍降压片联合替米沙坦对原发性高血压病患者Hcy和hs-CRP水平的影响[J].辽宁中医杂志,2018,45(9):1906-1908.
[11] 陈偶英,张 稳,简伟雄,等.复方七芍降压片合替米沙坦治疗高血压左心室肥厚肝肾阴虚、瘀血生风证及改善舒张功能的临床观察[J].湖南中医药大学学报,2014,34(6):26-30.
[12] Kawada T.Obstructive sleep apnea and left ventricular hypertrophy in obese children with hypertension[J].Journal Clin Hypertens,2020,22(2):305.
[13] Waldron PB,Kisser JE,Brody A,et al.MRI and neuropsychological correlates in African Americans with hypertension and left ventricular hypertrophy[J].Am Journal Hypertens,2018,31(8):865-868.
[14] Bruno A,Brooks DD,Abrams TA,et al.Left ventricular hypertrophy in acute stroke patients with known hypertension[J].Clin Exp Hypertens,2017,39(6):502-504.
[15] Verdecchia P,Angeli F,Aita A,et al.Blood pressure:The lower the better?maybe yes[J].Ital Cardiol,2016,17(5):335-338.
[16] 王顺民,黄 露,陈 橙,等.复方七芍降压片对自发性高血压大鼠血清炎症反应因子含量和血管组织学的影响[J].世界中医药,2021,16(4):576-580.
[17] 李 弘,刘叶倩,龚 姗,等.基于AKT/mTOR信号通路探讨复方七芍降压片治疗自发性高血压大鼠的作用机制[J].北京中医药大学学报,2020,43(4):296-303.
[18] 谭元生,邓圣明,谭 超.复方七芍降压片治疗高血压病的临床疗效及机理研究[J].中成药,2004,26(1):71-73.
[19] 王 婷,张 稳,罗 勇,等.复方七芍降压片治疗肝肾阴虚型高血压患者的临床疗效及对患者血浆Ang-Ⅱ、ANP水平的影响研究[J].辽宁中医杂志,2018,45(6):1225-1227.
[20] 罗 洁,王晓春,付祖姣,等.ATIR116641C和CYP11B2-344C/T基因多态性与湖南汉族原发性高血压的相关性[J].临床检验杂志,2011,29(6):451-453.
[21] 王顺民,曾 勇,黄 露,等.基于P2Y6受体探讨复方七芍降压片作用机制[J].中医药导报,2020,26(12):14-18.
[22] 蔺晓源,刘 丹,曾 勇.复方七芍降压片保护自发性高血压大鼠血管内皮损伤的作用研究[J].中国中医急症,2016,25(12):2220-2222.
[23] 龚 姗,李 弘,刘叶倩,等.复方七芍降压片对高血压大鼠LVH及心肌MMPs和p-P65表达的影响[J].中药材,2020,43(3):725-729.
[24] 龚 姗,李 弘,刘叶倩,等.复方七芍降压片对TNF-α诱导的与平滑肌细胞共培养的血管内皮细胞中炎症因子与AP-1、MCP-1蛋白表达的影响[J].中国实验动物学报,2020,28(6):733-741.
[25] 刘叶倩,李 弘,龚 姗,等.复方七芍降压片对TNF-α诱导的与平滑肌细胞共培养的血管内皮细胞P2Y6信号通路相关因子表达的影响[J].中国中医药信息杂志,2020,27(11):58-65.
[26] 任卫琼,李 弘,刘叶倩,等.复方七芍降压片对SHR大鼠IL-8、IL-10水平及AP-1、MCP-1蛋白表达的影响[J].中成药,2020,42(4):1031-1034.
[27] 李 苏,王雯雯,谭元生.复方钩藤降压片对SHR左室肥厚及血清瘦素和脂联素的影响[J].中医药导报,2018,24(15):53-55,58.
[28] 冯 宇,俞赟丰,周曼丽,等.复方钩藤降压片干预高血压左心室肥厚血浆代谢组学的通路分析[J].中国医药导报,2019,16(30):126-129,135.
[29] 李 颖,黄 桢,张 婷,等.眩晕3号方治疗原发性高血压左室肥厚35例[J].陕西中医,2017,38(9):1155-1156.
[30] 王 敏,吴春立,魏芳晶,等.视黄酸相关孤儿受体-白介素-23信号通路诱导病理性Th17细胞分化介导血压升高机制研究[J].陕西医学杂志,2021,50(4):398-402.
[31] 温 洁,邢 军,左振伟.护骨因子、白介素-1β、肝细胞生长因子对孕中、晚期妊娠糖尿病合并妊娠期高血压疾病孕妇血糖和血压的影响[J].中国医学前沿杂志:电子版,2020,12(4):39-43.
[32] Yao W, Sun YM, Wang XC,et al. High prevalence of metabolic syndrome in a middle-aged and elderly population with prehypertension in Tianjin[J].Clinical and Experimental Hypertension,2015,37(5):369-374.
[33] 丁秀婷,刘 璠,刘建一,等.银杏内酯B对自发性高血压大鼠心肌纤维化及左心室肥厚的影响研究[J].陕西医学杂志,2017,46(7):823-825.
[34] 赵玉琦.血清尿酸及NT-proBNP在评估老年原发性高血压患者左室肥厚中的意义[J].陕西医学杂志,2017,46(4):484-485,500.

相似文献/References:

[1]杨 敏,姜钧文,肖 蕾.中医体质与急性心肌梗死及其危险因素的相关性研究*[J].陕西中医,2019,(4):437.
　YANG Min,JIANG Junwen,XIAO Lei..Study on the correlation between constitution of traditional Chinese medicine and acute myocardial infarction and its risk factors[J].,2019,(9):437.
[2]高京宏,于 龙 △,王翠娟.大秦艽汤治疗颈椎病性高血压临床研究[J].陕西中医,2019,(5):597.
　GAO Jinghong,YU Long,WANG Cuijuan..Clinical observation of Daqinjiao decoction in the treatment of cervical spondylotic hypertension[J].,2019,(9):597.
[3]侯红霞,张春红.熄风通络汤联合西药治疗对高血压患者血管内皮功能的影响*[J].陕西中医,2019,(7):875.
　HOU Hongxia,ZHANG Chunhong..Effects of Xifeng Tongluo decoction combined with western medicine on vascular endothelial function in patients with hypertension[J].,2019,(9):875.
[4]钱卫东,侍煜景△.宁脉安神颗粒治疗女性更年期高血压疗效及对患者中医证候、血压变异性的影响*[J].陕西中医,2019,(9):1202.
　QIAN Weidong,SHI Yujing..Effects of Ningmai Anshen granule on TCM syndrome and blood pressure variability in women with climacteric hypertension[J].,2019,(9):1202.
[5]郭春霞,陈震霖△.中医从心肝肾论治高血压病现代作用机制及优势探讨*[J].陕西中医,2020,(5):650.[doi:DOI:10.3969/j.issn.10007369.2020.05.027]
　GUO Chunxia,CHEN Zhenlin..Study on Modern mechanism and advantage of TCM treating hypertension on aspects of the heart,liver and kidney[J].,2020,(9):650.[doi:DOI:10.3969/j.issn.10007369.2020.05.027]
[6]钟 路,尹胡海,黄 婕,等.从热毒学说论治高血压*[J].陕西中医,2020,(8):1131.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.032]
　ZHONG Lu,YIN Huhai,HUANG Jie,et al.Treatment of hypertension by heat toxicology[J].,2020,(9):1131.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.032]
[7]朱舜明,张学军,张荣怀,等.生脉注射液联合靶剂量比索洛尔对高血压伴心力衰竭患者血管内皮功能和心功能的影响*[J].陕西中医,2020,(10):1403.[doi:DOI:10.3969/j.issn.1000-7369.2020.10.017]
　ZHU Shunming,ZHANG Xuejun,ZHANG Ronghuai,et al.Effects of Shengmai injection combined with target dose bisoprolol on vascular endothelial function and cardiac function in patients with hypertension and heart failure[J].,2020,(9):1403.[doi:DOI:10.3969/j.issn.1000-7369.2020.10.017]
[8]欧阳雅蓉,傅为武,黄彩依,等.自噬在高血压靶器官损害中的作用及中医药治疗研究进展*[J].陕西中医,2020,(11):1669.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.040]
[9]王辞晓,赵良斌,黄佑群.益气活血补肾方联合厄贝沙坦对高血压性肾损害患者肾功能的保护作用[J].陕西中医,2021,(6):735.[doi:DOI:10.3969/j.issn.1000-7369.2020.06.014]
　WANG Cixiao,ZHAO Liangbin,HUANG Youqun.Protective effect of Yiqi Huoxue Bushen recipe combined with irbesartan on renal function in patients with hypertensive renal damage[J].,2021,(9):735.[doi:DOI:10.3969/j.issn.1000-7369.2020.06.014]
[10]邱思婕,李新梅.平肝化痰法联合西药治疗老年高血压疗效及对患者血压变异性、臂踝脉搏波传导速度、踝臂指数的影响[J].陕西中医,2021,(8):1056.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.017]
　QIU Sijie,LI Xinmei.Clinical curative effect of Pinggan Huatan method combined with western medicine on elderly hypertension and its influences on blood pressure variability,brachial-ankle pulse wave velocity and ankle-brachial index[J].,2021,(9):1056.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.017]

备注/Memo

备注/Memo:
基金项目:广西壮族自治区卫生健康委员会自筹经费科研课题(Z20200831)
更新日期/Last Update: 2022-09-08